MacDonald Glen C has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 76247 shares of Carisma Therapeutics Inc. ($CARM) on March 02, 2023.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 76247 | $0.59 | 206,751.0000 | 0 | 26.94% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | M | Common Stock | 183317 | $0.59 | 390,068.0000 | 0 | 88.67% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 60237 | $0.59 | 329,831.0000 | 0 | 15.44% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | M | Common Stock | 102975 | $0.59 | 432,806.0000 | 0 | 31.22% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 33888 | $0.59 | 398,918.0000 | 0 | 7.83% | 0.00% |
| Feb. 21, 2023 | Carisma Therapeutics Inc. | $CARM | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 25927 | $0.59 | 282,998.0000 | 0 | 8.39% | 0.00% |